LAVA Therapeutics
LVTX
LVTX
13 hedge funds and large institutions have $34.1M invested in LAVA Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.79M | |
| 2 | +$343K | |
| 3 | +$63.5K | |
| 4 |
Axa
Paris,
France
|
+$5.47K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$953K | |
| 3 | -$379K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$330K |
| 5 |
Millennium Management
New York
|
-$262K |